In a strategic move reflecting the evolution of global healthcare logistics, Pharma.Aero has expanded its Advisory Board and extended its mandate to two years for the first time. This decision supports greater continuity, deeper cross-industry engagement, and more sustained strategic input across the organization’s initiatives.
The newly elected Advisory Board brings together 13 senior leaders from Pharma.Aero member companies, representing the full healthcare logistics value chain – from pharmaceutical manufacturing to airports, airlines, ocean shipping, freight forwarding, and ground handling. The expanded composition mirrors the increasingly interconnected, multimodal, and complex nature of modern healthcare supply chains.
2026 – 2027 Advisory Board Composition
Pharmaceutical Manufacturing
Amgen – Elena Mishina, Global Transportation Excellence, EMEA & JAPAC Lead
Ferring Pharmaceuticals – Katharina Tyrakowska, Senior Manager PM and ESG
Johnson & Johnson – Victoria Wilmore, Director, External Supply Services MTO Digital Operations & Technical Services (DOTS) J&J Innovative Medicine
Pfizer – Can Pekerbas, Director, APAC & Speciality Logistics Transport Solutions Operations Lead, Pfizer Global Supply – Global Logistics and Network Servicesn
Freight Forwarders
DHL Global Forwarding – Andreas Beran, Head of Life Sciences & Healthcare Germany
NX Group – Samuel Speltdoorn, Global Head of Healthcare Solutions
Ground Handlers
Dnata – Haris Raza, Chief Operating Officer Cargo
Swissport – Andreas Behnke, CEO & Station Manager Basel-Mulhouse, Head of Cargo CHIF
Airports
DFW International Airport – Milton De La Paz, Vice President of Airline Relations and Cargo
Motiva Aeroportos – Lilian Françoso, Freight Manager
Airlines
Etihad Cargo – Fabrice Panza, Global Head of Pharma Solutions
Qatar Airways Cargo – Rashmi Karnad, Manager Pharma Product
Ocean Freight
Maersk – Sebastian Steinmüller, Global Product Owner Pharma Cold Chain Management
Strategic role and governance alignment
Since 2021, the Advisory Board works in close coordination with the Pharma.Aero Board of Directors, serving as a strategic sounding board across the organization’s research projects, publications, data initiatives, and executive education programs.
The expanded Advisory Board reflects how healthcare logistics operates today: across modes, regions, and responsibilities. By bringing together manufacturing, infrastructure, and logistics execution under one advisory framework, Pharma.Aero reinforces its role as a neutral, cross-industry collaboration platform. The Advisory Board’s input is essential to ensuring that our initiatives remain relevant, balanced, and firmly grounded in operational reality.
By combining perspectives from manufacturing through to global distribution nodes, the Advisory Board supports cross-industry alignment, contributes strategic guidance, and helps shape Pharma.Aero’s thought leadership and educational activities throughout the 2026–2027 term.